Q4 2024 Holdings
Filed 2025-02-11 | 3016 holdings | $10.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ramaco Resources Inc B(METCB) | EQUITY | 75134P501 | $1.0K | 102 | 0.0% |
| Verrica Pharmaceuticals Inc | EQUITY | 92511W108 | $2.7K | 3,807 | 0.0% |
| Q32 BIO Inc(QTTB) | EQUITY | 746964105 | $4.2K | 1,228 | 0.0% |
| Aerovate Therapeutics Inc | EQUITY | 008064107 | $5.9K | 2,226 | 0.0% |
| Elevation Oncology Inc | EQUITY | 28623U101 | $5.9K | 10,488 | 0.0% |
| Cibus Inc(CBUS) | EQUITY | 17166A101 | $8.4K | 3,008 | 0.0% |
| Inovio Pharmaceuticals Inc(INO) | EQUITY | 45773H409 | $9.3K | 5,106 | 0.0% |
| Shattuck Labs Inc(STTK) | EQUITY | 82024L103 | $9.5K | 7,864 | 0.0% |
| Skye Bioscience Inc(SKYE) | EQUITY | 83086J200 | $9.8K | 3,462 | 0.0% |
| Actinium Pharmaceuticals Inc(ATNM) | EQUITY | 00507W206 | $10.0K | 7,915 | 0.0% |
| ALX Oncology Holdings Inc(ALXO) | EQUITY | 00166B105 | $10.3K | 6,148 | 0.0% |
| Climb BIO Inc(CLYM) | EQUITY | 28658R106 | $10.6K | 5,869 | 0.0% |
| Pepgen Inc(PEPG) | EQUITY | 713317105 | $11.8K | 3,123 | 0.0% |
| Kyverna Therapeutics Inc(KYTX) | EQUITY | 501976104 | $12.7K | 3,385 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | EQUITY | 75382E109 | $12.7K | 8,018 | 0.0% |
| Hillevax Inc | EQUITY | 43157M102 | $13.2K | 6,358 | 0.0% |
| Pyxis Oncology Inc(PYXS) | EQUITY | 747324101 | $15.3K | 9,818 | 0.0% |
| Agenus Inc(AGEN) | EQUITY | 00847G804 | $15.8K | 5,766 | 0.0% |
| Black Diamond Therapeutics I(BDTX) | EQUITY | 09203E105 | $16.0K | 7,468 | 0.0% |
| Applied Therapeutics Inc(APLT) | EQUITY | 03828A101 | $16.5K | 19,329 | 0.0% |
| Generation BIO Co(GBIOGBX) | EQUITY | 37148K100 | $16.7K | 15,793 | 0.0% |
| Optimizerx Corp(OPRX) | EQUITY | 68401U204 | $17.2K | 3,532 | 0.0% |
| Harvard Bioscience Inc(HBIO) | EQUITY | 416906105 | $17.3K | 8,194 | 0.0% |
| TPI Composites Inc(TPICQ) | EQUITY | 87266J104 | $17.5K | 9,270 | 0.0% |
| Solid Biosciences Inc(SLDB) | EQUITY | 83422E204 | $18.1K | 4,528 | 0.0% |
| Alto Neuroscience Inc(ANRO) | EQUITY | 02157Q109 | $18.3K | 4,320 | 0.0% |
| Orchestra Biomed Holdings in(OBIO) | EQUITY | 68572M106 | $18.7K | 4,671 | 0.0% |
| B. Riley Financial Inc(RILY) | EQUITY | 05580M108 | $19.0K | 4,132 | 0.0% |
| IGM Biosciences Inc(1K0) | EQUITY | 449585108 | $19.3K | 3,156 | 0.0% |
| Stem Inc | EQUITY | 85859N102 | $19.4K | 32,110 | 0.0% |
| Tenaya Therapeutics Inc(TNYA) | EQUITY | 87990A106 | $19.4K | 13,577 | 0.0% |
| Contango ORE Inc(CTGO) | EQUITY | 21077F100 | $19.5K | 1,944 | 0.0% |
| Adverum Biotechnologies Inc(AVU0) | EQUITY | 00773U207 | $19.5K | 4,182 | 0.0% |
| Regulus Therapeutics Inc(RGLS) | EQUITY | 75915K309 | $20.1K | 12,696 | 0.0% |
| Scpharmaceuticals Inc(SCPH) | EQUITY | 810648105 | $20.2K | 5,708 | 0.0% |
| Contineum Therapeutics Inc A(CTNM) | EQUITY | 21217B100 | $20.5K | 1,396 | 0.0% |
| Cassava Sciences Inc(SAVA) | EQUITY | 14817C107 | $21.1K | 8,950 | 0.0% |
| Editas Medicine Inc(EDIT) | EQUITY | 28106W103 | $21.3K | 16,786 | 0.0% |
| Renovaro Inc(ENOBGBP) | EQUITY | 29350E104 | $21.5K | 25,695 | 0.0% |
| Virco MFG Corporation(VIRC) | EQUITY | 927651109 | $21.5K | 2,100 | 0.0% |
| Virgin Galactic Holdings Inc(SPCE) | EQUITY | 92766K403 | $21.7K | 3,691 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | EQUITY | 528872302 | $21.9K | 29,715 | 0.0% |
| Lyell Immunopharma Inc | EQUITY | 55083R104 | $22.4K | 35,001 | 0.0% |
| Quest Resource Holding Corp(QRHC) | EQUITY | 74836W203 | $22.5K | 3,468 | 0.0% |
| Bluebird BIO Inc(BLE0) | EQUITY | 09609G209 | $22.8K | 2,731 | 0.0% |
| Joint Corp(JYNT) | EQUITY | 47973J102 | $23.3K | 2,189 | 0.0% |
| Lineage Cell Therapeutics in(LCTX) | EQUITY | 53566P109 | $23.3K | 46,405 | 0.0% |
| Tscan Therapeutics Inc(TCRX) | EQUITY | 89854M101 | $23.5K | 7,720 | 0.0% |
| Enanta Pharmaceuticals Inc(ENTA) | EQUITY | 29251M106 | $23.9K | 4,163 | 0.0% |
| Foghorn Therapeutics Inc(FHTX) | EQUITY | 344174107 | $24.0K | 5,078 | 0.0% |